Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Changes in SHBG levels don't predict diabetes risk reduction.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Methotrexate may help stabilize frontal fibrosing alopecia.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Strontium ranelate is no longer available for treatment.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Early diagnosis of alopecia frontal fibrosante is crucial, but treatment remains controversial and varies.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Frontal fibrosing alopecia is increasingly affecting men, causing hair loss around the hairline and possibly other areas.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

A rare case of a man having both frontal fibrosing alopecia and vitiligo was reported.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Hepatitis C treatment may cause frontal fibrosing alopecia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Personalized supplements are important for women's health, but hormone therapy can increase cancer and heart risks.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.